Avantor Inc.May 27, 2025

FDA 483 - Avantor Inc. - May 27, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avantor Inc.

Record Details

An FDA inspection of Avantor Performance Materials, LLC in Phillipsburg, NJ, an API manufacturer, identified one observation. The firm was cited for not verifying the suitability of test methods for active pharmaceutical ingredients under actual conditions of use. Specifically, analytical method verification studies for USP methods used in release and stability testing for API products marketed in the U.S. were not completed.

Company: Avantor Inc.
Inspection Date: May 27, 2025
Product Type: Drugs
Office: New Jersey District Office
Person: Robin P. Mathew

Open in Dashboard

ID · 9a1900f5-cdc4-41fa-9589-e6108fa4a2d2